EUVIMEDEUVIMED entdecken
Crossref

From SHP2 to DDR1-ERK: A critical signaling axis controlling microglial activation and neuropathic pain after spinal cord injury

Wei Zhang, Zhenwei Xu

General physiology and biophysics · 2026 · 45 (04) · 409-418

DOI: 10.4149/gpb_2026009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift General physiology and biophysics, 2026. Verfasst von Wei Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, Xi'an International Medical Center Hospital, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Protein Tyrosine Phosphatase, Non-Receptor Type 11, Microglia, Neuralgia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explores the role of the src homology-2domain-containing protein tyrosine phosphatase-2 (SHP2)-discoid domain receptor 1 (DDR1)-extracellular signal-regulated kinase (ERK) signaling axis in neuropathic pain following spinal cord injury (SCI). Rats were transfected with LV-shSHP2 before SCI modeling. Hind limb function and paw withdrawal threshold were assessed using the Basso-Beattie-Bresnahan (BBB) scale, and Von Frey filaments, respectively. The effects of SHP2 knockdown on microglial activation and DDR1/SHP2/ERK pathway were examined by Western blotting and immunofluorescence. To further validate the regulatory mechanism of SHP2 in SCI, lipopolysaccharide (LPS)-activated BV-2 microglial cells were subjected to SHP2/DDR1 knockdown, or DDR1 overexpression. Results showed that SCI induced motor deficits, mechanical allodynia, and upregulation of spinal SHP2, DDR1, and p-ERK/ERK ratio, alongside microglial activation. These changes were reversed by LV-shSHP2 treatment. In LPS treated BV-2 cells, DDR1 overexpression promoted cell activation and ERK phosphorylation, while counteracting the effects of LV-shSHP2; however, DDR1 knockdown produced the opposite effects. A direct interaction between SHP2 and DDR1 was confirmed. In conclusion, SHP2 knockdown suppresses microglial hyperactivation and alleviates SCI-induced neuropathic pain by downregulating the DDR1-ERK signaling pathway, during which SHP2-DDR1 interaction has been confirmed as a key regulatory mechanism. Targeting this specific interaction axis may offer a novel therapeutic strategy for neuropathic pain management by selectively disrupting microglial activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesProtein Tyrosine Phosphatase, Non-Receptor Type 11MicrogliaNeuralgiaDiscoidin Domain Receptor 1Extracellular Signal-Regulated MAP KinasesMAP Kinase Signaling SystemAnimalsRatsRats, Sprague-DawleySignal TransductionMaleCell Line

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 11Discoidin Domain Receptor 1Extracellular Signal-Regulated MAP KinasesPtpn11 protein, rat

Autor:innen und Institutionen

  • Department of Spine Surgery, Xi'an International Medical Center Hospital, Xi'an, Shaanxi, China.
  • Department of Trauma Orthopedics, Xi'an International Medical Center Hospital, Xi'an, Shaanxi, China.

Zitieren

APA

Zhang, W., & Xu, Z. (2026). From SHP2 to DDR1-ERK: A critical signaling axis controlling microglial activation and neuropathic pain after spinal cord injury. General physiology and biophysics, 45(04), 409-418. https://doi.org/10.4149/gpb_2026009

Vancouver

Zhang W, Xu Z. From SHP2 to DDR1-ERK: A critical signaling axis controlling microglial activation and neuropathic pain after spinal cord injury. General physiology and biophysics. 2026;45(04):409-418. doi:10.4149/gpb_2026009

BibTeX
@article{Zhang2026,
  author = {Zhang, Wei and Xu, Zhenwei},
  title = {From SHP2 to DDR1-ERK: A critical signaling axis controlling microglial activation and neuropathic pain after spinal cord injury},
  journal = {General physiology and biophysics},
  year = {2026},
  volume = {45},
  number = {04},
  pages = {409--418},
  doi = {10.4149/gpb_2026009}
}
Kostenlos starten →